The biggest reason why shares of Alphabet trade at a discount to its peers is that the market is worried about its base ...

Indian equities are bracing for high volatility as key domestic and global triggers — from the RBI policy decision and major ...

Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...

Microsoft soared past US$4 trillion in market valuation, becoming the second publicly traded company after Nvidia to surpass ...

IonQ combines strong cash reserves, technical advantages, and key partnerships for long-term quantum growth despite near-term ...

After disappointing performance following its initial public offering in 2021, Dutch Bros (NYSE: BROS) rewarded investors' ...

Exchange-traded funds come in a multitude of 'flavors' these days, from passive to active to factor-based. Their flexibility ...

In terms of fundamentals, Pfizer currently boasts a market capitalization of $132 billion. Over the last twelve months, the ...

In recent forecasts, Vanguard projects the stock market will rise by only 3.3% to 5.3% a year over the next decade.

Medtronic is two years shy of being a Dividend King and it has a historically high 3% yield.

Helped by higher advertising and a growing user base on its social media platforms, Meta earned $18.34 billion in the quarter ...

Alex Illingworth of Goshawk Asset Management highlights three diverse opportunities in global equities despite a turbulent ...